Lexaria Bioscience Corp. (LEXX)
NASDAQ · Healthcare
Lexaria Bioscience Corp. Total Liabilities 2016–2025
Lexaria Bioscience Corp. annual total liabilities history from 2016 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Lexaria Bioscience Corp. total liabilities as of August 31, 2025: 1.6M, a 30.08% increase year-over-year.
- Lexaria Bioscience Corp. total liabilities for 2025 were 1.6M, a 30.08% increase from 2024.
- Lexaria Bioscience Corp. total liabilities for 2024 were 1.2M, a 199.26% increase from 2023.
- Lexaria Bioscience Corp. total liabilities for 2023 were 403,908, a 100.51% increase from 2022.
- Lexaria Bioscience Corp. total liabilities for 2022 were 201,437.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Lexaria Bioscience Corp. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $2 |
| 2024 | $1 |
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $0 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $0 |
Lexaria Bioscience Corp. Total Liabilities — FAQ
Lexaria Bioscience Corp. (LEXX) total liabilities over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see LEXX's total liabilities history?
The chart and table above show Lexaria Bioscience Corp.'s total liabilities by year and by quarter, including the growth rate.